Injectable medicine shown to reduce the spread of HIV by 99 percent.
The Food and Drug Administration (FDA) announced on Monday that it had approved a new drug to fight against the spread of HIV. Apretude, the name of the new treatment, is an injectable drug that is an alternative to Truvada and Descovy which are administered as pills. The Apretude treatment was found to reduce the chance of contracting the disease by 99 percent.
Director of the FDA’s Division of Antivirals and Center for Drugs Evaluation and Research Dr. Debra Birnkrant, said, “Today’s approval adds an important tool in the effort to end the HIV epidemic by providing the first option to prevent HIV that does not involve taking a daily pill.” She added, “This injection, given every two months, will be critical to addressing the HIV epidemic in the U.S.”
As the Lord Leads, Pray with Us…
- For wisdom for FDA officials as they assess treatments to approve.
- That the president and his administration would seek the Lord’s direction as they address health issues in the U.S.
- For Dr. Birnkrant as she oversees the development of antiviral treatments.
Sources: NBC, The Hill, Washington Post
